Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics reported a strong Q1-FY27 with revenue reaching INR 2,315 Mn and EBITDA margins expanding to 17.97%, the highest in six quarters, driven by raw material savings and operating leverage.
Valiant Organics reported a significant FY26 turnaround with Revenue of ₹7,388 Mn (+3% YoY) and PAT of ₹332 Mn, recovering from a loss. Performance was driven by structural cost optimization and improved realizations.